Suppr超能文献

流感对氨基金刚烷类药物的耐药特性。

Resistance characteristics of influenza to amino-adamantyls.

作者信息

Astrahan Peleg, Arkin Isaiah T

机构信息

Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences. The Hebrew University of Jerusalem, Edmund J. Safra Campus, Jerusalem 91904, Israel.

出版信息

Biochim Biophys Acta. 2011 Feb;1808(2):547-53. doi: 10.1016/j.bbamem.2010.06.018. Epub 2010 Jun 27.

Abstract

The recent outbreaks of avian flu in Southeast Asia and swine flu in Mexico City painfully exemplify the ability of the influenza virus to rapidly mutate and develop resistance to modern medicines. This review seeks to detail the molecular mechanism by which the influenza virus has obtained resistance to amino-adamantyls, one of only two classes of drugs that combat the flu. Amino-adamantyls target the viral M2 H(+) channel and have become largely ineffective due to mutations in the transmembrane domain of the protein. Herein we describe these resistance rendering mutations and the compounded effects they have upon the protein's function and resulting virus viability.

摘要

近期东南亚爆发的禽流感以及墨西哥城爆发的猪流感,痛苦地例证了流感病毒迅速变异并对现代药物产生耐药性的能力。本综述旨在详细阐述流感病毒对氨基金刚烷类药物产生耐药性的分子机制,氨基金刚烷类药物是仅有的两类抗流感药物之一。氨基金刚烷类药物作用于病毒的M2 H(+)通道,由于该蛋白跨膜结构域发生突变,这类药物已基本失效。在此,我们描述这些导致耐药性的突变以及它们对蛋白功能和病毒生存能力产生的复合效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验